Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 83 (ZNF83) is a member of the Krüppel-associated box (KRAB) C2H2-type zinc finger protein family, which acts as a transcription factor and is involved in the regulation of gene expression via DNA binding. Located on chromosome 19q13.41, ZNF83 participates in fundamental cellular processes including transcriptional repression, cell proliferation, apoptosis, and maintaining genomic integrity. It is differentially expressed across multiple cancer types, with upregulation associated with poor prognosis in renal cell carcinoma and downregulation in other tumor contexts, suggesting a context-dependent role in tumor progression. ZNF83 is emerging as a potential prognostic biomarker, especially in kidney cancer, but its utility as a direct drug target has not yet been established[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 83 (ZNF83).